TD Cowen analyst Charles Rhyee raised the firm’s price target on CVS Health (CVS) to $80 from $73 and keeps a Buy rating on ...

Fintel reports that on November 25, 2024, TD Cowen initiated coverage of Viridian Therapeutics (NasdaqCM:VRDN) with a Buy ...

Fintel reports that on November 25, 2024, TD Cowen downgraded their outlook for Despegar.com (NYSE:DESP) from Buy to Sell.

Life Science Tools and Diagnostics stocks are viewed favorably at TD Cowen despite concerns over Trump's policies and his HHS ...

TD Cowen analyst Derrick Wood maintained a Buy rating on Microsoft (MSFT – Research Report) today and set a price target of $475.00. The ...

On Friday, Xylem Inc (XYL) stock saw a modest uptick, ending the day at $121.78 which represents a slight increase of $0.15 or 0.12% from the prior close of $121.63. The stock opened at $121.73 and ...

As reported by the Globe and Mail, TD analyst David Kwan November 22 launched coverage of VHI with a “Buy” rating and a ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

Onex Corp. shares are climbing after the Canadian investment firm shed its only neutral rating, with TD Cowen upgrading the ...

TD Cowen's bullish report explains MicroStrategy's strategic shift to Bitcoin, foreseeing its rise as a superior store of value. Investment banking company, TD Cowen, published a recent report on ...

As previously reported, TD Cowen analyst Mario Mendonca upgraded Scotiabank (BNS) to Buy from Hold with an C$80 price target The firm, which believes ROE is “among the most important financial ...